Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
06 Noviembre 2023 - 8:28AM
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage
biotechnology company pioneering the development of bi-functional
fusion proteins as a new class of biologic medicine for the
treatment of patients with cancer and autoimmune disease, today
announced it will report its third-quarter 2023 financial results
and provide a general business overview on Thursday, November 9,
2023.
Title: Shattuck Labs Third-Quarter 2023
Earnings Call
Speakers: Taylor Schreiber, CEO; Andrew Neill,
CFO; Lini Pandite, CMO
Date & Time: Thursday, November 9, 2023 at
8:00 a.m. ET
Dial-in Details: Toll-Free Dial-In Number: 1
(888) 440-4368
Toll Dial-In Number: 1 (646) 960-0856
Conference ID: 5023003
Webcast
Details: https://events.q4inc.com/attendee/625426190
To listen to the live webcast, please visit the Investor
Relations page of the Shattuck Labs website here. Participants may
register for the call here. While not required, interested
participants are encouraged to join 10 minutes prior to the start
of the event.
A replay of the webcast will be available following the
conclusion of the live call and will be accessible on the Company’s
website.
About Shattuck Labs, Inc.Shattuck Labs, Inc.
(NASDAQ: STTK) is a clinical-stage biotechnology company pioneering
the development of bi-functional fusion proteins as a new class of
biologic medicine for the treatment of patients with cancer and
autoimmune disease. Compounds derived from Shattuck’s proprietary
Agonist Redirected Checkpoint, (“ARC®”), platform are designed to
simultaneously inhibit checkpoint molecules and activate
costimulatory molecules with a single therapeutic. The company’s
lead SL-172154 (SIRPα-Fc-CD40L) program, which is designed to block
the CD47 immune checkpoint and simultaneously agonize the CD40
pathway, is being evaluated in multiple Phase 1 trials. Shattuck
has offices in both Austin, Texas and Durham, North Carolina. For
more information, please visit: www.ShattuckLabs.com.
The Company intends to use the investor relations portion of its
website as a means of disclosing material non-public information
and for complying with disclosure obligations under Regulation
FD.
Investor & Media Contact: Conor
RichardsonVice President of Investor RelationsShattuck Labs,
Inc.InvestorRelations@shattucklabs.com
Shattuck Labs (NASDAQ:STTK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Shattuck Labs (NASDAQ:STTK)
Gráfica de Acción Histórica
De May 2023 a May 2024